Table 1.
Across all samples | Nonrecurrent Patients | Recurrent Patients | Reinfected Patients | All Patients | P |
---|---|---|---|---|---|
# Patients (% of Total Patients) | 20 (32.8) | 28 (45.9) | 13 (21.3) | 61 | - |
Age, mean (±SD) | 58.3 (±20.3) | 56.4 (±17.4) | 58.6 (±15.7) | 55.2 (±18.7) | .89 |
Female gender, n (%) | 10 (50) | 18 (64.2) | 6 (46.1) | 34 (55.7) | .5 |
PPI use, n (%) | 7 (35) | 5 (17.9) | 3 (25) | 15 (24.6) | .4 |
Prior antibiotic use | 7 (35) | 6 (21.4) | 2 (15.4) | 15 (24.6) | .4 |
Concurrent antibiotics, n (%) | 16 (80) | 15 (53.6) | 7 (53.8) | 38 (62) | .1 |
Mean # samples per patient [IQR] | 1.3 [1,1.25] | 2.11 [1,3] | 1.54 [1,2] | 1.72 [1,2] | .00023 |
Mean # colonies isolated | 33.6 [26.3, 40] | 35.1 [25, 44] | 29.1 [13.5, 40] | 33.6 [21, 43] | .48 |
# samples with mixed infection (% samples in group) | 12/26 (46.2) | 42/59 (71) | 8/20 (40) | 62/105 (59) | .015 |
Mean # of unique ribotypes in samples with mixed infection [IQR] | 2.67 [2,3] | 2.71 [2,3] | 2.25 [2,2] | 2.65 [2,3] | .49 |
Most common dominant ribotype | F014-020 | F027 | F078-126 | F014-020 | .38 |
| |||||
At Index Sampling (1st documented CDI episode) | Nonrecurrent Patients | Recurrent Patients | Reinfected Patients | All Patients | |
| |||||
# Index samples available (% samples in group) | 19 (18.1) | 14 (13.3) | 3 (2.9%) | 36 (34.3) | - |
# Index samples with mixed infection (% index samples in group) | 7/19 (36.8) | 11/14 (78.6) | 1/3 (33.3) | 19/36 (52.8) | .047 |
Mean # of ribotypes in index samples with mixed infection [IQR] | 3 [2,3] | 2.38 [2,3] | 2 [2,2] | 2.57 [2,3] | .59 |
Most common dominant ribotype (index) | F002 | F027 | F019 | F027 | - |
P values: Chi-squared test for categorical variables; ANOVA for continuous variables